Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome - Wikidata - awgldk - TriplyDB

Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome

Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome

http://www.wikidata.org/entity/Q34718837

about

Novelty in hypertension in children and adolescents: focus on hypertension during the first year of life, use and interpretation of ambulatory blood pressure monitoring, role of physical activity in prevention and treatment, simple carbohydrates and Uric acid in metabolic syndrome: From an innocent bystander to a central player Animal models of metabolic syndrome: a review Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis Evaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patients Redefining metabolic syndrome as a fat storage condition based on studies of comparative physiology Racial/ethnic and sex differences in the relationship between uric acid and metabolic syndrome in adolescents: an analysis of National Health and Nutrition Survey 1999-2006.Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey.Xanthine oxidase inhibition by febuxostat attenuates stress-induced hyperuricemia, glucose dysmetabolism, and prothrombotic state in mice Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes.Fructose and uric acid: is there a role in endothelial function?Sugar, uric acid, and the etiology of diabetes and obesity.Comorbidities in patients with crystal diseases and hyperuricemia.Sexually dimorphic effect of in vitro fertilization (IVF) on adult mouse fat and liver metabolomes Overnutrition, mTOR signaling, and cardiovascular diseases.The association between shift work and hyperuricemia in steelmaking male workers The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality Absence of functional leptin receptor isoforms in the POUND (Lepr(db/lb)) mouse is associated with muscle atrophy and altered myoblast proliferation and differentiation.Febuxostat, an inhibitor of xanthine oxidase, suppresses lipopolysaccharide-induced MCP-1 production via MAPK phosphatase-1-mediated inactivation of JNK The pathophysiology of hypertension in patients with obesity.Serum uric acid levels are associated with hypertension and metabolic syndrome but not atherosclerosis in Chinese inpatients with type 2 diabetes Hyperuricemia causes pancreatic β-cell death and dysfunction through NF-κB signaling pathway.Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes Plasma Levels of Uric Acid, Urea and Creatinine in Diabetics Who Visit the Clinical Analysis Laboratory (CAn-Lab) at Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.Hyperuricemia as a Potential Determinant of Metabolic Syndrome.A Risk Score with Additional Four Independent Factors to Predict the Incidence and Recovery from Metabolic Syndrome: Development and Validation in Large Japanese Cohorts Uric acid is an independent risk factor for carotid atherosclerosis in a Japanese elderly population without metabolic syndrome Uric Acid Produces an Inflammatory Response through Activation of NF-κB in the Hypothalamus: Implications for the Pathogenesis of Metabolic Disorders Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Tromsø Study.Higher blood hematocrit predicts hyperuricemia: a prospective study of 62,897 person-years of follow-up.Dose-response Relationship of Serum Uric Acid with Metabolic Syndrome and Non-alcoholic Fatty Liver Disease Incidence: A Meta-analysis of Prospective Studies Association between sex-specific serum uric acid and non-alcoholic fatty liver disease in Chinese adults: a large population-based study.Association between IL-6 and related risk factors of metabolic syndrome and cardiovascular disease in young rats.Low adiponectin is associated with diastolic dysfunction in women: a cross-sectional study from the Tromsø Study.Effects of febuxostat on platelet-derived microparticles and adiponectin in patients with hyperuricemia.Perspective: A Historical and Scientific Perspective of Sugar and Its Relation with Obesity and Diabetes.Association analysis between genetic variants in interleukin genes among different populations with hyperuricemia in Xinjiang Autonomous Region Protective effect of rosiglitazone, quercetin, and their combination on fructose-induced metabolic syndrome in rats.Macrophage functions in lean and obese adipose tissue.Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver.

P2860

Q26740021-A8AACCD7-0CC3-4EB0-ABDC-FC6E5FA00CCB Q26772053-A8153A8C-8DE5-4F8A-B841-64B47ED10DBA Q28072861-855897E5-3779-429C-B3A0-1AECEA10C0BE Q28354735-9C9EABC0-2504-49A3-B8E3-2BB7E64B6743 Q28542043-68E1A9D8-EC23-4778-9690-ABEAABACF83C Q28687768-4FC1CDA8-6EAB-41DF-8F1C-A97E42F5F03B Q30421679-4B757FA8-50DD-4E52-B8C0-63F7B5EA0ABF Q30572017-D319CABC-9430-4FE1-84B5-9F26A4E0AA1D Q33683082-83910C73-688A-4415-A52F-9B3A17B9A001 Q33731729-C2582B32-CC06-43C7-A037-649C28047971 Q33854358-CA00FC0B-9C89-4382-ABCA-51BD8C26BC1F Q34038315-9D3A872B-2A12-483C-8B8D-D7923C939C44 Q34157725-B6305F36-D5D9-4F71-BF9F-D0F895EA481E Q34343095-554E560D-9175-4401-B39A-E69FDBDDDD5B Q34519316-B3D4CA1A-D8CA-4D83-B3EB-F7E38BC4E301 Q34789441-FA969F02-74E2-4AAD-8ADC-9C6DF12983EA Q34877729-0C003C68-BFE3-496F-B791-2235525A3FC3 Q34965072-494C86C5-6D7C-42CD-AB45-9B602077AEC6 Q35005708-42EE143F-83CE-44A8-A3DB-326063F96520 Q35021492-D9EBC562-ED48-4935-A69F-0C307CF528A3 Q35023207-67CFF29B-5B46-4805-A813-B50597FB9A1B Q35036279-4BBD349A-2BB1-4F7A-A623-15B68333C161 Q35184941-3655B60D-B51E-4364-8D8A-03FD5C6BC663 Q35230438-C4075171-A447-4575-AF16-E468775AA9CA Q35332690-F24200EF-5817-4010-8E37-7C5B22339D38 Q35730666-73ED3C66-8C91-466C-81CA-DBAC0884EECC Q35802376-940255A6-4F93-494A-A1F7-51E73711C641 Q35856483-223484C4-4B0B-4140-8EE0-ABBE1076844C Q36013899-86ECC66A-ED1F-4F1A-B332-0955125375BD Q36026612-699925EE-3BA4-4F73-964F-B7485FE7F748 Q36099467-A824B66F-3DDE-4788-805D-475BB8BFBCBE Q36153675-C91E4E15-8850-419B-A1F2-EF6E28EB9658 Q36183112-818BBD3A-7438-4BDE-9EE0-D1E90DF26C3D Q36307705-38472A52-EC9E-421E-BB50-AFC41CF2F948 Q36331121-60165FFE-743B-45BC-9BBC-C88A3BE26EA2 Q36372585-FC02EA3D-230A-46EF-82A8-491183F2FF25 Q36375514-AD3917CB-D9D5-4065-BE77-746CF57F292E Q36398157-9A9F6622-B9A0-4E77-A01F-FE85D8185DF9 Q36412774-D5D3FDFD-F056-4441-8EEC-74EEC8BA24C3 Q36418940-8CD7EF61-E184-4CE0-8625-DC0F2C7786D2

P2860

Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome

http://www.wikidata.org/entity/Q34718837

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Hyperuricemia as a mediator of ...... odel of the metabolic syndrome

@ast

Hyperuricemia as a mediator of ...... odel of the metabolic syndrome

@en

Hyperuricemia as a mediator of ...... odel of the metabolic syndrome

@nl

type

label

Hyperuricemia as a mediator of ...... odel of the metabolic syndrome

@ast

Hyperuricemia as a mediator of ...... odel of the metabolic syndrome

@en

Hyperuricemia as a mediator of ...... odel of the metabolic syndrome

@nl

prefLabel

Hyperuricemia as a mediator of ...... odel of the metabolic syndrome

@ast

Hyperuricemia as a mediator of ...... odel of the metabolic syndrome

@en

Hyperuricemia as a mediator of ...... odel of the metabolic syndrome

@nl

P1433

Q34718837-00CED738-5EE2-4F5F-953E-E46EC0940F76

P1476

Q34718837-AF916BA5-AFDF-49CC-BF20-620088AF935E

P2093

Q34718837-22B5896E-99CD-4C47-9CBE-6BF9293FA9D3

Q34718837-2B820C81-6F3D-47FD-905D-2E7D673FF004

Q34718837-A1ACD58C-93E1-4ED0-B09D-BC7B75C1618F

Q34718837-A5418C3B-32DF-4132-B07D-D157BE7D5ED4

Q34718837-AE1D621C-1F9A-436C-9F96-DFE634B9401C

Q34718837-B951222D-F6A3-4EA0-9504-043F7644DC72

Q34718837-D21422A4-C77F-479E-BA40-7435E3BB9BB7

Q34718837-DA1293AC-738B-4C98-825F-915BE928D250

P2860

Q34718837-0ACB7E75-37E2-4A10-A904-699332DE4399

Q34718837-0E73A079-E99F-4B02-BAC6-D759A66693C1

Q34718837-11A35B5E-D70D-45C0-B0D0-245F9D052899

Q34718837-1511CDCA-5520-4B4E-8DD2-174D0953FB9D

Q34718837-16932E07-55D9-4694-963D-BDF4210C4699

Q34718837-19A47C65-AC75-4B3F-9FAB-67C27CDD1E20

Q34718837-19B13CB1-CE92-41FF-BE3A-665D32DD0604

Q34718837-1ED56630-16B4-4D26-A0D2-500338DA86A8

Q34718837-21DCE645-2883-4344-9069-ADFD005BFCEC

Q34718837-27044532-3C55-4045-9F63-3D56B289534B

P304

Q34718837-021B7666-6F41-4664-980F-5D644D03B724

P31

Q34718837-22DA3158-5DAC-4113-9D9F-DF153BAAA484

P356

Q34718837-A36F0770-6709-48B1-A819-6EFE5464AD68

P407

Q34718837-DC07A0D1-CC4B-48A2-A0CB-7D897E0B0829

P433

Q34718837-CF471B71-2FF9-47D8-98CE-4DE70AAC8765

P478

Q34718837-6B5786C5-3FC6-4BB3-8CD7-E398130E6FB5

P577

Q34718837-611E40F2-33DE-49B5-A253-E05F1F18ED0C

P5875

Q34718837-CE95B051-320C-48B4-8168-6E21E661B3E6

P698

Q34718837-3987B115-815A-46D2-B334-02C8C1407A8A

P921

Q34718837-EF0C6241-3748-48EF-B91C-9B4D67C9EB00

P932

Q34718837-01FB0CF1-1B7C-46AA-A370-FB5D7789BA7E

P356

P1433

P1476

Hyperuricemia as a mediator of ...... odel of the metabolic syndrome

@en

P2093

Chris Baylis

http://www.w3.org/2001/XMLSchema#string

David Wymer

http://www.w3.org/2001/XMLSchema#string

George Marek

http://www.w3.org/2001/XMLSchema#string

Richard J Johnson

http://www.w3.org/2001/XMLSchema#string

Steven McRae

http://www.w3.org/2001/XMLSchema#string

Varinderpal Pannu

http://www.w3.org/2001/XMLSchema#string

William Baldwin

http://www.w3.org/2001/XMLSchema#string

Yuri Y Sautin

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation, stress, and diabetes

Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

Obesity is associated with macrophage accumulation in adipose tissue

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

Increased oxidative stress in obesity and its impact on metabolic syndrome

MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity

How dying cells alert the immune system to danger

Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome

Molecular identification of a danger signal that alerts the immune system to dying cells

P304

1258-1269

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB10-0916

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49966887

http://www.w3.org/2001/XMLSchema#string

P698

21346177

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

P932

3064099

http://www.w3.org/2001/XMLSchema#string